Pregnant Women With Severe or Critical Coronavirus Disease 2019 have Increased Composite Morbidity Compared With Nonpregnant Matched Controls
C.A. DeBolt, A. Bianco, Mr. Anand Limaye, J. Silverstein, C.A. Penfield, A.S. Roman, H.M. Rosenberg, L. Ferrara, C. Lambert, Rawan Khoury, P.S. Bernstein, J. Burd, V. Berghella, E. Kaplowitz, J.R. Overbey, J. Stone
Abstract
( Am J Obstet Gynecol . 2021;224:510.e1–510.e12. doi: 10.1016/j.ajog.2020.11.022. Epub November 20, 2020) The global coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) leads to mostly mild adverse outcomes. Due to the physiological changes during pregnancy, pregnant women are more susceptible to infection and respiratory issues. Thus, there is cause for concern that morbidity and mortality will increase for pregnant women with COVID-19 compared with nonpregnant women. This study aimed to better understand the course of COVID-19 comparing pregnant and nonpregnant women and analyzing severe and critical cases of each population.